AbTx: drug-conjugated immunotherapy for targeting resistant tumors
6 May 2026The startup AbTx, which specializes in immuno-oncology, aims to tackle the most difficult-to-treat cancers using a breakthrough technology: ...
Find out moreFor all the latest about the agency, businesses and local areas